Just when it looks like it’s time for the device industry to karaoke some Alanis Morissette and find a new partner than venture capital, there is a little hope. Despite the 29 percent drop in venture capital funding to medical devices in the first half of 2013, Minneapolis VC firm SightLine Partners has closed a $107 million fund that will go into direct investments in late-stage medtech companies. Its Healthcare Opportunity Fund II, which the company began seeking last year, was even oversubscribed by $7 million.
“Our investment strategy is well-suited to the current financing environment in the medical technology marketplace, where many late-stage companies are requiring more capital and time to achieve a successful exit,” Joe Biller, managing director at Sightline, said, according to the release.
This deal scored Scott Ward a boost from venture partner to managing director.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The company does not disclose the names of portfolio companies, according to its website, but recently made an investment in CVRx.